GSK Taps Genedata's Software to Support Antibody Research and Development | GenomeWeb

NEW YORK (GenomeWeb) – Genedata said this week that GlaxoSmithKline's biopharma research and development arm has selected its Genedata Biologics software to handle data management and workflow support needs.

The Genedata Biologics platform will support multiple groups within GSK including teams working on lead identification and screening, protein optimization and engineering, and protein production. GSK will use the system to record, manage, share, and process data from its antibody discovery platforms, including its phage and yeast display, hybridoma, and other technologies.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

This Week in Science: New research into the emergence of infectious diseases, and scientists report on proteins involved in melanoma.

The hashtag #stupidcommonnames is gaining fans among scientists who find the common names of some animals and plants dumb.

Fed up with budget slashes, job cuts, and muzzling mandates, researchers in Canada are making science a campaign issue in the upcoming elections.

A former NIH program officer says the Internet has blasted open the door for scientific publications more interested in dollars than quality research.